rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Gland Pharma Ltd.

543245 GLAND Group (A)

01 Nov,18:59
1647.00
-3.85 (-0.23%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Gland Pharma Ltd.

BUYSELL

1,137 1,650.85 1,662.00 - 1,640.00 2,220.95 - 1,488.00 27,142.57
NSE | BSE

Gland Pharma Ltd.

GLAND

01 Nov,19:19
1646.35
-4.75 (-0.29%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Gland Pharma Ltd.

BUYSELL

20,971 1651.1 1,659.45 - 1,637.45 2,220.95 - 1,486.65 345.94

News for Gland Pharma Ltd.

Gland Pharma...
Gland Pharma Appoints Shyamakant Giri as CEO
Gland Pharma has appointed Shyamakant Giri as its new CEO, effective January 15, 2025. Giri currently serves as President of Amneal Pharmaceuticals.
Oct 18, 2024 18:52
Lupin Partners...
Lupin Partners with Scope Ophthalmics for Mexican Eyecare Market
Lupin has partnered with Scope Ophthalmics to market a range of eyecare products in Mexico, including products for dry eyes, blepharitis, and MGD.
Sep 30, 2024 17:54
Gland Pharma Q1 Profit Down 26% to Rs 144 Cr
Gland Pharma's Q1 profit fell 26% to Rs 144 crore, while revenue rose to Rs 1,402 crore. The company remains confident about its fiscal year goals.
Aug 06, 2024 19:21
KKR Acquires Baby Memorial Hospital for Rs 2k cr
Global PE major KKR acquires a controlling stake in Kerala-based Baby Memorial Hospital for Rs 2,000 crore, aiming to expand its healthcare network in India.
Jul 01, 2024 20:01
Fosun Sells 6%...
Fosun Sells 6% Stake in Gland Pharma for Rs 1,754 Crore
Fosun Pharma has divested a 6% stake in Gland Pharma for Rs 1,754 crore through an open market transaction, reducing its shareholding to 51.86%. UBS Principal Capital Asia acquired a 0.5% stake.
Jun 19, 2024 21:50

More News for Gland Pharma Ltd. »

(Rs. Crore)

Financial Results of Gland Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales4,167.433,616.534,400.713,462.882,633.24
Operating profit1,408.781,018.551,510.641,302.27955.47
Interest7.847.415.243.417.18
Gross profit1,567.601,251.601,729.341,433.631,087.45
EPS (Rs)63.3447.1173.7860.9549.88

See more in Research Center »

News for Pharmaceuticals and health care

Coal India Aims...
Coal India Aims for Dividend Return by FY'26
Coal India aims to eliminate ECL's losses and rejoin the dividend list by FY'26, with subsidiary Bharat Coking Coal already achieving this. The company also plans to boost production and reduce...
Nov 03, 2024 19:01
Gold Poised for...
Gold Poised for 15-18% Returns in Samvat 2081: Analysts
Analysts predict a strong 15-18% return for gold in Samvat 2081, driven by positive economic factors and safe-haven demand. Learn about the outlook for gold and silver in the new financial year.
Nov 03, 2024 18:31
Punjab Paddy...
Punjab Paddy Procurement Crosses 85 Lakh Tonnes: Centre
Punjab has procured 85.41 lakh tonnes of paddy in the 2024-25 kharif marketing season, with procurement operations now in full swing. The Centre has fixed a target of 185 LT for the state.
Nov 03, 2024 17:15
Microsoft Sees No...
Microsoft Sees No Tech Spend Slowdown in India, AI, Copilot Driving Growth
Microsoft India President Puneet Chandok highlights strong tech spending in India, driven by AI and Copilot adoption, and emphasizes the company's commitment to responsible AI development.
Nov 03, 2024 16:56
Sebi Fines Sunil...
Sebi Fines Sunil Lulla Rs 50 Lakh for Market Norm Violations
Sebi has imposed a Rs 50 lakh fine on Sunil Lulla, former MD of Eros International, for violating market norms in a case related to possible fund diversion. The regulator found Lulla non-compliant...
Nov 03, 2024 16:15

More News »

Top News

Coal India Aims...
Coal India Aims for Dividend Return by FY'26
Coal India aims to eliminate ECL's losses and rejoin the dividend list by FY'26, with subsidiary Bharat Coking Coal already achieving this. The company also plans to boost production and reduce...
Nov 03, 2024 19:01
Gold Poised for...
Gold Poised for 15-18% Returns in Samvat 2081: Analysts
Analysts predict a strong 15-18% return for gold in Samvat 2081, driven by positive economic factors and safe-haven demand. Learn about the outlook for gold and silver in the new financial year.
Nov 03, 2024 18:31
Punjab Paddy...
Punjab Paddy Procurement Crosses 85 Lakh Tonnes: Centre
Punjab has procured 85.41 lakh tonnes of paddy in the 2024-25 kharif marketing season, with procurement operations now in full swing. The Centre has fixed a target of 185 LT for the state.
Nov 03, 2024 17:15
Microsoft Sees No...
Microsoft Sees No Tech Spend Slowdown in India, AI, Copilot Driving Growth
Microsoft India President Puneet Chandok highlights strong tech spending in India, driven by AI and Copilot adoption, and emphasizes the company's commitment to responsible AI development.
Nov 03, 2024 16:56
Business School Applications Surge Despite Economic Uncertainty
Applications for business school graduate programmes soared 12% in 2024, driven by renewed interest in full-time, in-person offerings and increased financial aid.
Nov 03, 2024 16:44

More Top News »

Report Card

PE Ratios
26.00
EPS (Rs.)
63.34
Sales (Rs. Cr)
1,012.02
Face Value (Rs.)
1
Net Profit Margin (%)
25.03
Last Bonus
Last Dividend(%)
2000
Return on Average Equity
11.6

Compare 'Gland Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,849.05
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,202.15
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,001.85
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,020.70
  • Compare
  • Max Healthcare Institute Ltd.
  • 1,016.65
  • Compare
  • Divi's Laboratories Ltd.
  • 5,893.90
  • Compare
  • Alkem Laboratories Ltd.
  • 5,783.95
  • Compare

Most Active

  • Change (Rs.)
  •  

Gland Pharma Ltd. performance snapshot

If you had invested Rs.  in Gland Pharma Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Gland Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Gland Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close